| Financial Year |
March 31 2023 |
| Monetary Funds |
2,259,033,242.29 |
| Held-for-trading Financial Assets |
407,729,378.89 |
| Notes Receivable |
750,102,367.21 |
| Accounts Receivable |
1,030,696,245.36 |
| Advances to Suppliers |
272,682,314.97 |
| Other Receivables |
22,818,115.02 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
406,544.60 |
| Dividend Receivable |
-- |
| Inventories |
1,826,647,089.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
2,213,761.47 |
| Other Current Assets |
400,546,169.05 |
| Total Current Assets |
7,582,602,652.23 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
10,665,842.92 |
| Long-term Equity Investment |
1,879,329,701.59 |
| Investment Properties |
58,224,417.82 |
| Fixed Assetes |
6,455,264,955.77 |
| Under-construction Projects |
5,020,979,148.29 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
677,567,594.33 |
| R&D expenses |
-- |
| Goodwill |
16,004,611.13 |
| Long-Term Deferred and Prepaid Expenses |
53,880,405.13 |
| Deferred Income Tax Assets |
172,682,042.31 |
| Other Non-Current Assets |
57,591,864.91 |
| Sub-Total of Non-Current Assets |
15,232,780,932.52 |
| Total Assets |
22,815,383,584.75 |
| Short-Term Loans |
131,753,336.39 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,590,965,792.19 |
| Accounts Payable |
2,201,137,843.17 |
| Accounts Received In Advance |
9,023,787.94 |
| Employee Compensation Payable |
49,588,702.27 |
| Taxes Payable |
114,401,023.68 |
| Interest Payable |
-- |
| Dividend Payable |
600,000.00 |
| Other payables |
350,267,772.69 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
57,447,389.07 |
| Other Current Liabilities |
35,297,132.08 |
| Sub-Total of Current Liabilities |
4,857,556,968.17 |
| Long-term Loans |
1,400,680,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
97,814,123.07 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
22,613,349.52 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,021,934,331.58 |
| Total Liabilities |
6,879,491,299.75 |
| Paid-In Capital(Or Share Stock) |
2,699,746,081.00 |
| Capital Surplus |
4,289,874,680.77 |
| Surplus Reserve |
884,949,000.65 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
7,622,202,369.37 |
| Minority Stockholder's Interest |
306,596,960.22 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
15,629,295,324.78 |
| Owner's Equity（Stockholder's Equity） |
15,935,892,285.00 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
22,815,383,584.75 |
